dc.contributor.author | Suleymanova, Vafa | |
dc.contributor.author | Cifcibasi, Ash Ormeci | |
dc.contributor.author | Karahan, Latif | |
dc.contributor.author | Kapar, Caner | |
dc.contributor.author | Cavus, Bilger | |
dc.contributor.author | Atasoy, Alp | |
dc.contributor.author | Isik, Akin | |
dc.contributor.author | Kaymakoglu, Sabahattin | |
dc.contributor.author | Besisik, Fatih | |
dc.contributor.author | Demir, Kadir | |
dc.contributor.author | Akyuz, Filiz | |
dc.date.accessioned | 2021-03-02T16:15:42Z | |
dc.date.available | 2021-03-02T16:15:42Z | |
dc.identifier.citation | Kapar C., Cavus B., Atasoy A., Suleymanova V., Isik A., Karahan L., Cifcibasi A. O. , Akyuz F., Demir K., Besisik F., et al., "TENOFOVIR DISOPROXIL FUMARATE IN CHRONIC HEPATITIS B: WHAT ARE THE TRIGGERS OF DRUG-RELATED ADVERSE EFFECTS?", Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), ELECTR NETWORK, 13 - 16 Kasım 2020, cilt.72 | |
dc.identifier.other | av_39e229f2-9470-46a4-bc97-19c05dd7ae4c | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/2675 | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Gastroenteroloji-(Hepatoloji) | |
dc.subject | GASTROENTEROLOJİ VE HEPATOLOJİ | |
dc.subject | Klinik Tıp (MED) | |
dc.title | TENOFOVIR DISOPROXIL FUMARATE IN CHRONIC HEPATITIS B: WHAT ARE THE TRIGGERS OF DRUG-RELATED ADVERSE EFFECTS? | |
dc.type | Bildiri | |
dc.contributor.department | İstanbul Üniversitesi , , Dahili Tıp Bilimleri Bölümü | |
dc.identifier.volume | 72 | |
dc.contributor.firstauthorID | 2288178 | |